Bio-Techne (MEX:TECH) Selling, General, & Admin. Expense: MXN6,588 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:TECH Bio-Techne Corp MEX:TECH
85 GF Score
Price MXN1,090.00
GF Value MXN1,102.98
! 8 Warning Signs
View Full Analysis

What is Bio-Techne Selling, General, & Admin. Expense?

Bio-Techne MEX:TECH 85 Selling, General, & Admin. Expense is MXN6,588 Mil as of Mar. 2026. GuruFocus rates MEX:TECH with a GF Score™ of 85/100 and a GF Value™ of MXN1,102.98. The stock has 8 warning signs investors should review.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Bio-Techne's selling, general, & admin. expense for the three months ended in Mar. 2026 was MXN1,972 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2026 was MXN6,588 Mil.


Bio-Techne  (MEX:TECH) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Bio-Techne Selling, General, & Admin. Expense Related Terms


Bio-Techne Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for Bio-Techne's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Techne Selling, General, & Admin. Expense Chart

Bio-Techne Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,771.23 6,820.02 6,042.16 7,205.66 7,815.94

Bio-Techne Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,094.69 437.14 2,131.84 2,047.09 1,971.66

MEX:TECH vs ARWR, CYTK, KRYS: Selling, General, & Admin. Expense Comparison

For the Biotechnology subindustry, Bio-Techne's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Techne Selling, General, & Admin. Expense vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Techne's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Bio-Techne's Selling, General, & Admin. Expense falls into.


MEX:TECH
85GF Score
Bio-Techne Corp MEX:TECH
Selling, General, & Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Techne Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN6,588 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling, General, & Admin. Expense of MXN6,588 Mil mean?
Bio-Techne (MEX:TECH) has a Selling, General, & Admin. Expense of MXN6,588 Mil as of Mar. 2026. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Bio-Techne and its competitors.
Is Bio-Techne's Selling, General, & Admin. Expense too high?
Bio-Techne's current Selling, General, & Admin. Expense is MXN6,588 Mil. Overall, Bio-Techne has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's Selling, General, & Admin. Expense compare to ARWR and CYTK?
Bio-Techne's Selling, General, & Admin. Expense of MXN6,588 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Biotechnology company?
A good Selling, General, & Admin. Expense depends on the Biotechnology industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Bio-Techne and its competitors. Bio-Techne's current Selling, General, & Admin. Expense is MXN6,588 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Bio-Techne (MEX:TECH) has a current Selling, General, & Admin. Expense of MXN6,588 Mil. The stock's GF Value™ is MXN1,102.98, compared to a current price of MXN1,090.00 — trading 1.2% below its estimated fair value. The current Selling, General, & Admin. Expense is MXN6,588 Mil. Bio-Techne's overall GF Score™ is 85/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Bio-Techne (MEX:TECH), the current Selling, General, & Admin. Expense is MXN6,588 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Techne (MEX:TECH) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued. The current stock price of MXN1,090.00 is trading 1.2% below its estimated GF Value™ of MXN1,102.98.

Key valuation signals for MEX:TECH:

  • Selling, General, & Admin. Expense: MXN6,588 Mil
  • GF Value™: MXN1,102.98 vs. price of MXN1,090.00 (1.2% below fair value)
  • GF Score™: 85/100 with 8 warning signs

No single metric tells the full story. See the MEX:TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bio-Techne Business Description

Address 614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
85GF Score

Get the complete analysis for MEX:TECH

Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,090.00
Price
MXN1,102.98
GF Value